Describe the criteria based on which you select the manufacturers of laboratory instruments?

The most important criteria is the quality and after sales support which we look for before any possible association.

Tell us about the features of lab instruments that you supply to the pharma/ biotech industry?

After sales and services is key for all the products that we supply to pharma/ biotech/ research organisations. However, we have a wide range of products and each product has its own unique feature/s viz. Miele Professional is a brand we represent for automated glassware washer and disinfectors.

Features of Miele Professional

Miele Professional is a German company which has been in the washing business since the last 130 years. The company manufactures each component in-house including motors and electronics unlike all competitors who outsource most of the components and then assemble them at their factories. It is compliant with all regulatory authorities and certifications across globe, one of the most important factors in the pharma sector. Apart from this, unique features include patented variable speed motor with in-built heating elements, sensors for spray arms to ensure that there are no blockages, pH monitoring with pre-set value to ensure perfect cleaning and, if values doesn’t match, automatic modifier of rinse cycle with user intervention, 3-staged-HEPA filters for drying, pre-programmes for all types of wash possibilities like oil/ grease/ organic/ inorganic/ blood etc.

Supported by trained engineers at the German factory with ample spare support to ensure the least down time. Similarly, all our products have distinguishing features.

Which brands do you represent?

We represent ThermoFisher, US, Bio-Rad laboratories, US, Miele-Germany, Nabertherm-Germany, Post-Nova- Germany, Kruss- Germany, Solaris-Italy.

Who are your clients?

Major pharma companies across the country namely, Lupin, Serum, Zydus, Cadila, Reliance, Dr Reddy’s Laboratories, IPCA, Sun Pharma, Emcure, USV and many more.

Major research institutes like IITs, ACTREC, AIIMS, NIPER, IISER, NCCS, PERD, NIPERs, NCL, NIV, NIO, NCBS,CCMB and many more.

Major hospitals in our clients’ list are Jaslok, Hinduja, KEM, JJ, KDAH, TMH etc.

What is your annual turnover?

Our annual turnover is Rs 25 crores.

How do you manage to keep imported products cost effective for your clients?

We have all options for clients for direct import as well as bonded warehouse facilities to get optimum cost effectiveness.

Do you have any new products in the pipeline?

We are working on developing general purpose products locally, with international quality and aesthetics, under the ‘Make in India’ plan. We will launch the same in the last quarter of 2016.

sachin.jagdale@expressindia.com

The post ‘We have a wide range of products with unique features’ appeared first on Express Pharma.

Agarwal Movers Group, a major player in the relocation industry, announced an investment of Rs 100 crore in Trucking Cube (http://www.truckingcube.com), which has reportedly introduced the concept of transporting goods in ‘cubes’ exclusively assigned to them. This prevents shipments like pharmaceutical and food products, from damage as the shipment makes its way through the supply chain. The cubes come in six sizes — 4, 6, 8, 12, 16 and 20 feet.

According to a press release, a study carried out over the past years by Agarwal Movers Group has shown that the country sees an annual damage of over Rs 42,000 crores in transhipment due to surface logistics. Trucking Cube assures safe-delivery of goods with Zero Transhipment, Zero Damage, Zero Loss to its house-hold and commercial customer by protecting goods from expiring before the expiry date. The goods are transported in ‘cubes’ exclusively assigned to them avoiding any rancidity/ damage. This problem is more prevalent in food and pharma industry and has a direct impact on the health of the consumer and can prove fatal for the brand’s name. Agarwal Movers Group will move 100 per cent to Trucking Cube by July 2016.

The company looks at the pharma industry as one of its most important clients. Since many of the pharma products are temperature sensitive they are making special arrangements for the same. Saransh Agarwal, Director and Head, Trucking Cube Division, Agarwal Movers Group , informs, “Currently, we are working on the trial version of how the goods will be maintained at room temperature. Once we are done with our study and the entire process is evaluated with two to three companies and if they give their go ahead then a significant percentage of cubes will be as per the pharma industry’s requirements. For the specific temperature requirements of the pharma industry, we will be launching reefer containers/ cubes in the second phase.”

“Trucking Cube assures zero transhipment, improved efficiency by 200 per cent and six per cent reduction in the packaging cost. The Rs 100-crore investment will be made over the next three years to grow the ecosystem and the number of cubes to 10,000 from 2,000,” said Ramesh Agarwal, Chairman, Agarwal Movers Group, further pointing out that choosing the incorrect logistics partner could ruin the brand’s reputation overnight.

EP News Bureau – Mumbai

The post Agarwal Movers Group invests Rs 100 crores in Trucking Cube appeared first on Express Pharma.

Research has shown that some injectable drug vial systems can effectively be utilised to freeze, store and ship cryopreserved living cell products in a format that enables large-scale manufacturing and fill-finish operations, in addition to providing caregivers and patients with a system that is easy to handlei. This finding comes at a time when manufacturers are beginning to realise that the current blood-banking bag technology may not work on the scale they will require, as therapeutic cell products reach later stages of clinical trials.

Blood bags are sufficient for small-scale processes that generate tens of product doses per lot. However, commercial-scale sizes of hundreds to thousands of living cell doses per lot will be required to supply a commercial-scale cellular product, a volume that may preclude the use of bags. Thus, more consideration is being placed on manufacturing processes that are capable of producing commercial – scale quantities of living cell productsii.

With the emergence of cellular therapy as a more widely used clinical practice, improved containers and closure systems for effective, safe use and cell preservation are required. While still effective for some indications, there has been more focus on the shortcomings of cryopreserved bag storage. A study by Khuu et al investigated a series of catastrophic bag failures first noticed in 2001iii. In that study, high rates of bag failure were associated with four specific bag lots made from poly (ethylene co-vinyl acetate). While no serious adverse patient effects occurred, extensive bag failures led to microbial contamination of the cell product, along with increased product preparation time, antibiotic use and resource expenditure to replace products.

Pharma-grade vials provide  ease of delivery by caregivers. They also leverage the pharma manufacturing infrastructure. Importantly, there are established standards in sizes, quality and regulatory attributes that can be capitalised upon in order to facilitate uptake into the rapidly developing cell therapy industry.

The ideal vial-based container system should be suited for packaging, storing and transporting cell therapy products at low temperatures and meet pharma quality requirements to maintain cell viability over its intended shelf life. Polypropylene is a plastic resin that has been used for decades in various packaging applications, including bottles, pouches, tubes and containers. However, these plastic resins have made minimal headway in the area of parenteral vials and prefillable syringes owing to various quality attributesiv.

Recent availability of newer plastic resinsv with key features such as glass-like clarity, lower potential for extractables, allowing for various modes of sterilisation, very low moisture permeability, biocompatibility and lower particulates – has enabled the use of these superior plastics for pharmaceutical and biopharmaceuti­cal drug delivery applications. However, the use of vials has not yet been translated to cell-based biologic products, due in part to the lack of data on the ability of cells to be successfully cryopre­served and stored while maintaining viability and important functionalities relevant to therapies over a reasonable shelf life (e.g., six months).

In a recent study,i the suitability of a commercially available vial, West’s Daikyo Crystal Zenith, consisting of cyclic olefin polymer resin, was evaluated for low-temperature and cryopreserved storage of cell sys­tems. These vials are currently being used to package and deliver pharma drugs in global markets, and are in development for biologic drugs, such as peptides, proteins and monoclonal antibodies vi, vii, viii. Being nonpolar, this particular vial has low moisture absorption and excellent drainability, which prevents water and liquid drug preparations from adhering to the vial surface. It is compatible with a wide range of pHs (2–12) and solvents, such as alcohols, ketones and dimethyl sulfoxide. It also has excellent thermal characteristics and can withstand cryogenic temperatures as well as sterilisation by autoclaving. Compared with polypropylene, it also has lower gas and moisture permeabilityix. Furthermore, the pharma industry is already accustomed to the filling of various – sized vials with drug and biologic products on a large automated scale, which is not available for bags.

From a mechanical standpoint, the Crystal Zenith vials exhibited excellent durability. No study vial exhibited gross breakage or cracking after a frozen drop test, which involves freezing 60 per cent full vials, dropping them at a height of one meter at a 15o angle to the lab floor, thawing them, and visually inspecting them. Slight damage occurred occasionally to the flip-off caps, but this did not compromise the closure integrity as demonstrated by the post-thaw dye and microbial immersion studies performed fol­lowing typical transportation methods. These results, combined with the fact that none of the cell cultures became contaminated, provide good evidence that in any standard clinical application, vials provide robust container closure maintenance.

Overall, this initial proof-of-concept study indicated that the vials are highly suitable for cold and cryogenic storage of biological cells, and provide a suitable container system for clinical and commercial cell therapy products. The vials were easy to freeze and more convenient to use as compared with bags, as they could be adapted to existing storage configurations. From a practical stand­point, these vials are designed with standard dimensions (13 and 20 mm openings) that are capable of fitting into traditional pharma manufacturing filling lines.

Compliance with compendial requirements for containers and closures used in packaging sys­tems for cellular therapy applications should be evaluated based on the final use of the product. However, based on recent research, Crystal Zenith vials may be the ideal replacement for bags as cellular therapies scale up in use and production for today’s clinical pathways.

Reference:
i. Woods E, Aniruddha B, Goebel WS, Nase, R, Vilivalam, V: Container system for enabling commercial production of cryopreserved cell therapy products. Regen.Med. 5(4), 659-667(2010).
ii. Kirouac DC, Zandstra PW: The systematic production of cells for cell therapies. Cell Stem Cell 3, 369–381 (2008).
iii. Khuu HM, Cowley H, David-Ocampo V et al.: Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. Cytotherapy 4(6), 539–549 (2002).
iv. Akers MJ, Nail SL, Saffell-Clemmer W: Top ten topics in parenteral science and technology. PDA J. Sci. Technol. 61(5), 337–361 (2007).
v.  Eakins MN: New plastics for old vials. Bioprocess Int. 3(6), 52–58 (2005).
vi. Esfandiary R, Joshi SB, Vilivalam V, Middaugh CR: Characterization of protein aggregation and adsorption on prefillable syringe surfaces. Presented at: AAPS National Biotechnology Conference. Toronto, Canada, 22–25 June 2008.
vii. Waxman L, Vilivalam V: Development of analytical techniques to determine protein adsorption on sterilized parenteral packaging containers and stoppers. Presented at: AAPS National Biotechnology Conference. Seattle, WA, USA, 21–24 June 2009.
viii. Qadry SS, Roshdy TH, Char H, Del Terzo S, Tarantino R, Moschera J: Evaluation of CZ-resin vials for packaging protein-based parenteral formulations. Int. J. Pharm. 252, 207–212 (2003).
ix. Daikyo Resin CZ Technical Report, West Pharmaceutical Services (2002) www.westpharma.com/ap/en/products/ Pages/ CrystalZenithRU.aspx.

The post New age storage systems for cell therapy products appeared first on Express Pharma.

Complex coding requirements driven by serialisation regulations are creating an increased demand for multifaceted data management solutions. As a result, manufacturers are looking for printers equipped to handle vast data management responsibilities.

In India, the Directorate General of Foreign Trade (DGFT) is responsible for serialisation requirements for those companies looking to export pharmaceutical products to foreign markets. In January of this year an amendment to policy was announced with regard to ‘The implementation of track and trace requirements for the export of pharmaceuticals and drug consignments’i. At a primary level, companies were required to incorporate a 2D barcode encoding a unique and universal global product identification code in the form of a Global Trade Item Number (GTIN) – this also included a batch number, expiry date and a unique serial number. This bar code labelling at a primary level has been exempted by DGFT until further notice, but is required to be printed in human readable form on an optional basis.

On a secondary level, one or two dimensional barcodes including GTIN, expiry date and a unique serial number are required, while for outer cases one dimensional barcodes are stated with the same requirements. For parent child relationships – the relationship of the data between all three levels of packaging, with outer cases as parent to secondary and secondary as parent to primary packs – data must be uploaded onto a central portal (DAVA). Non-SSI (or large) manufacturers have been required to maintain records and report data to DAVA across all packaging levels since April 1, 2016, whereas SSI companies are only required to upload data at the outer casing level. After March 31, 2017, SSI companies will be required to perform the same level of data management and reporting as non-SSI.

How printers can help with data management?

Serialisation is impossible without coding and marking, and regulatory compliance is likewise impossible without accurate and effective data management. Printing solutions, such as thermal inkjet (TIJ) and laser coders, are designed to be highly versatile, with advanced communication and data handling capabilities, enabling them to integrate with whichever track and trace technology a manufacturer has adopted.

Asynchronous communications is one such capability. In the past, if there was an issue with a printer the management interface would have to send a message from the line management system to check whether it was functioning correctly – referred to as polling. The printer, in turn, would report back to the system that there was an issue. The latest technology allows the printer to send unsolicited information to the line control system the second there is a printer event. If you are dealing with a large amount of data, this proactive reporting of errors can help to achieve major savings in terms of stopping the line immediately and resolving issues quickly, leading to higher potential throughput and significantly reduced data traffic. It is preferable to polling as the data is received in real time.

Printer memory is also important when looking at serialisation solutions. Some serialisation solutions transfer serial numbers to the printer printed one record at a time, referred to as unbuffered printing. When multiple records are sent at once but printed only once each, a buffer is used to store numbers until they are printed, increasing the demands on the printer. If there is an unexpected stoppage on the line, intelligent coding devices are able to communicate which codes are still available for use, meaning codes can be reclaimed as opposed to wasted. This capability is especially relevant when codes have been purchased for use – as is the case with the Chinese government. The latest TIJ printer from Videojet, for example, has a buffer capacity to store hundreds of codes. An index is also kept of the last printed code, which allows manufacturers to continue from the correct code should the line be stopped for any reason.

In addition, given the global markets pharma manufacturers operate within, printers need to have the ability to operate using an extensive number of characters, including Cyrillic, Arabic and pan-Asian languages. By employing Unicode encoding technology, printers are able to encode over 1m characters, which in turn unlocks access to a wide range of global languages.As serialisation deadlines loom, and in some instances have passed, it is imperative that data is managed in an effective, accurate manner that will allow manufacturers to remain compliant and to continue running lines at optimum speeds. Ensuring your coding and marking systems are up to the job will be an essential element to consider, as serialisation simply cannot work without this vital piece of the puzzle.

Reference:
http://dava.gov.in/files/PublicNotice_05_2016.pdf

The post Effective data management to meet serialisation requirements appeared first on Express Pharma.

The three-day event, attended by 34,597 visitors, comprised a series of interesting seminars, workshops and presentations

ACREX INDIA 2016, one of the largest exhibitions on air conditioning, ventilation, refrigerating and building services showcased the manufacturing potential of domestic HVAC&R industry. Spread over three days at the Bombay Convention and Exhibition Centre, the event reportedly witnessed more than 400 exhibitors and 34,597 visitors. The exhibition was spread over a display area of 35,000 sq mts.

ACREX INDIA 2016 kicked off with a panel discussion on ‘Importance of Design and Architecture for Sustainability, Big Savings and Performance in the Long Run.’ The discussion was designed to promote ACREX INDIA’s vision of energy sustainability. The panelists included Arun Bhatia, Managing Director, UTC–Climate Controls & Security; Anuj Agarwal, Head, Infrastructure Management & Service Group, ICICI Bank; Rajan Rawal, Executive Director, Centre for Advanced Research in Building Science & Energy; T David Underwood, P Eng, Fellow ASHRAE Life Member, PRP Ramakrishnan, Area Director of Engineering –South Asia, Marriot International; and Pankaj Dharkar, Chair, Steering Committee of ACREX India 2016.

Primary discussions revolved around building management, performance and the related technology innovations, challenges in end-to-end mergers etc. The event witnessed an increase in global participation by major players. Special designated areas called ‘country pavilions’ were created to accommodate participants from Germany, the US, China and Turkey. The pavilions provided a great opportunity for domestic manufacturers and SMEs to ideate, network and get an understanding of current global trends in designing, energy sustainability andthe related product innovations primarily developed around air quality and refrigeration.

ACREX India 2016 witnessed participation from countries such as Korea, Japan, England, the UK, France, Canada, Taiwan, Singapore, New Zealand, Thailand, Czech Republic, Switzerland, Sweden, Malaysia, Vietnam and many more.

ACREX 2016 also organised ACREX Hall of Fame Awards. The event recognised key endeavours by the industry around energy sustainability and green initiatives. ACREX Awards of Excellence – recognition of product innovations and green technology and for the first time conceptualised by Danfoss, the hall of fame was introduced at the ACREX INDIA 2016.

The exhibition also served as a global networking platform for the industry with heads of international associations which included Associazione Italiana Frigoristi, The Federation of Thai Industries, Turkish HVAC-R Exporters Union, Air Conditioning and Refrigeration Manufacturers’ Association, American Society of Heating, Refrigerating, and Air-Conditioning Engineers, Society of Environmental Engineering, Eurammom, Air-Conditioning and Refrigeration Industry Club, Chinese Association of Refrigeration.

Indian Society of Heating, Refrigerating and Air Conditioning Engineers (ISHRAE) also organised Quest, a student quiz competition for the second year in a row, sponsored by Hitachi. The quiz was primarily designed to introduce engineering students to the HVAC&R industry.

ACREX India 2016 presented a series of educative sessions during the three-day event. The knowledge sessions provided an opportunity to gain market insights from professionals in the industry and acted as a platform to interact and share thoughts between the industry experts and attendees. The workshops and seminars were conducted by internationally acclaimed experts from the industry and provided a rare opportunity to the participants to learn, share expertise and hone their skills on the latest trends and topics related to HVAC&R industry. Various workshops were also organised to address issues related to industries like dairy, horticulture, food and vegetables.

EP News Bureau – Mumbai

The post ACREX INDIA 2016 demonstrates potential of domestic HVAC&R industry through sustained growth in manufacturing appeared first on Express Pharma.

Better quality or better yield is the primary reason for investing in a cleanroom space. Numerous manufacturing facilities now require a controlled environment in which the amount of dust and dirt can be limited in the manufacturing area. Medical instrument manufacturing and packaging, electronics and computer manufacturing, food preparation and some military applications are but a few of the instances that have strict requirements for maintaining a clean environment. One needs to know the requirement of specific product or process. Clean rooms have become integral part of pharma manufacturing facilities.

One of the important aspects of cleanrooms are the doors that are chosen for clean room facility. Time for which the door is open will play a critical factor in avoiding dust, outside temperature, humidity etc. Opening and closure of door has to be quick enough to isolate the outside environment and internal facility.

At Gandhi Automations, clean room high speed doors are provided which have been specifically designed for the above purpose. The clean room high speed doors are best suited for facilities where controlled environment is needed. The opening and closing of door is quick enough to separate outside environment and internal facility.

High speed clean room doors designed by Gandhi automation are engineered carefully with the following features:-

• Concept of low air permeability in pressurised rooms with positive and negative air pressure
• Designed to fit inside the columns
• Self-supporting construction
• Minimises air leakage
• Can be equipped with transparent PVC horizontal sections or vision windows
• Special side guides to tightly integrate the curtain
• High leak tightness due to the close filling curtain in the guide rails
• High door efficiency with and low permeability values, EN 12426 EN 12427: < 12 m3/m2 h D 50 PA .
• Control device enclosure in stainless steel SS 316

Contact Details:
Gandhi Automations
Chawda Commercial Centre,
Link Road, Malad (West),
Mumbai – 400064, India
Tel: +91-22-66720200 / 66720300 (200 lines)

The post Cleanroom doors by Gandhi Automations appeared first on Express Pharma.

Inflatable gaskets functions like a cycle tube. When inflated, it seals the gap and ensures proper sealing. It is made up of transparent silicone rubber. These gaskets are inflated by 6-10 mm when 2-4 kg pressure is applied.

These gaskets find application where gaps need to be sealed, which are uneven due to fabrication limitation such as in fluid bed dryer, sliding door autoclave, isolators. etc. There are in-house tool making facility in CMC and VMC. These gaskets are manufactured with world class European machine and advance technology. Raw materials used to manufacture these gaskets are sourced from the US and Europe.

Ami Polymer has also developed gaskets for isolator and glove box, fedegari, autoclave, autocoater, lypholiser.

Aapplication of inflatable gaskets

• Powder and bulk solid handling machineries
• Processing equipment
• Food processing equipment
• Conveyor
• Robotics and fluid sealing
• Material handling and medical sterilisers
• Electronic/ Wafer semiconductor processing
• Nuclear door seals
• Industrial washing and extractor machines
• Fluid bed dryers in pharma application
• Industries for inflatable gaskets
• Airlock door seals
• Personnel access door seals
• Equipment hatch seals
• Torus and wet well access hatch seals
• Refuelling canal hatch seals
• Pool gate seals
• Airlock shaft seals
• Dry well head seals
• Inflatable door and valve seals

Imaflexxie

General features

• Platinum cured silicone covered over stainless steel (SS 304) braided with inside PTFE tube.
• Permits easy cleaning.
• Pharmaceutical, food and beverage, and chemical applications.
• Smooth silicone cover provides safety to operator while handling in high temperature.
• Prevents operator/ users injury due to ‘frayed’ SS braids.
• Temperature rated -maximum temperature: -60ºC to +250ºC.
• Can be autoclaved.
• Excellent chemical compatibility with organic &inorganic solvent.
• Conforms to USFDA 21CFR 177.2600.

Application

• Fluid handling
• Pharmaceutical
• Food and beverage
• Cosmetics
• Steam application, Etc.

Construction

• Inside tube: Smooth PTFE for sterile application
• Cover: Platinum cured silicone
• Reinforcement: Stainless steel braiding

Note:- Corrugated PTFE can be made available for better flexibility and bending radius.

Contact Details:
Ami Polymer
Mahesh Industrial Estate,
Opp Silver Park,
Mira Bhayander Rd, Mira Road (East),
Thane – 401104
Tel: +91-22-28555107 / 631 / 914
Fax: +91-22-28555378
Email: info@amipolymer.com
Web: www.amipolymer.com

The post AMI Polymer unveils silicone inflatable gaskets and Imaflexxie appeared first on Express Pharma.

The new Luna Omega 1.6mm builds upon this legacy with an innovative UHPLC silica particle architecture, designed and manufactured by Phenomenex based on more than 20 years of applied knowledge, invention and customer experience. The new 1.6mm UHPLC columns deliver improved performance compared to other sub-2mm products on the market, along with exceptionally tight particle size distribution, high column packing efficiencies, steady selectivity and excellent reproducibility. Luna Omega columns are well suited for a wide range of applications including drug discovery and development, food contaminant analysis, environmental testing, toxicology and clinical research.

Luna Omega UHPLC columns feature a novel silica with a constant particle morphology that is modified with proprietary, post-synthetic thermal treatment processes for mechanical strength and inertness. This provides significantly better peak shape for compounds of interest and minimises unwanted secondary interactions. Proprietary Phenomenex bonding technologies ensure wide stationary phase coverage and excellent separation power.

Kinetex Core-Shell Technology and Luna Omega columns together provide an ideal complementary UHPLC solution for greater efficiency and separation power. With a growing range of valuable selectivities, this pairing of core-shell and fully porous UHPLC products affords customers a better choice for immediate gains in productivity, resolution and retention. Combinations such as such as Luna Omega 1.6mm C18 with Kinetex 1.7mm Biphenyl and Kinetex 1.7mm F5 promote greater method development success.

Contact Details:
Jennifer Dahlgren,
Dahlgren Communications
Tel: (530) 263-6817
Email: dahlgrenpr@comcast.net

Simon Lomas,
Phenomenex, Inc.
Tel: (310) 212-0555 (Extn. 2267)
Email: simonl@phenomenex.com

Website: www.phenomenex.com

The post Phenomenex launches Luna Omega 1.6µm columns appeared first on Express Pharma.

Bosch Packaging Technology, a leading supplier of process and packaging technology, has added a new topload cartoner to its well-known TTM product portfolio.

The proven features of the TTM platform have been advanced specifically for the packaging of ampoules, vials, syringes, pens and further products from the pharmaceutical industry. A simple and safe changeover concept, high process safety and a broad format and product flexibility characterise the machine. Due to its modular design, the machine layout can be adjusted to different product infeeds. With an output of 30 up to 200 cartons, the TTMP provides individual solutions for both small and large production batches.

The Sigpack TTMP can be seamlessly combined with the Sigpack TTMC case packer. This offers customers a uniform, user-friendly operating concept for the entire line.

Thanks to the patented format changeover concept, tool-less format changes with vertical restart can be carried out within a few minutes. The open and easily accessible machine design provides for a very fast line clearance.

A wide range of product infeed solutions and loading possibilities ensure the gentle handling of sensitive products such as vials, ampoules, syringes and injection pens. Various gripper technologies provide for smooth packaging of the products. Depending on requirements, different mechanic, vacuum-based or grippers with airflow technology are being used. Modules for forming and inserting partitioners, package inserts and tray denesting can also be integrated. Maximum efficiency and 100 per cent process safety.

The Sigpack TTMP is easily accessible and open. The compact, GMP-compliant design supports process safety. Additional Track & Trace-solutions such as the CPS module (Carton Printing System) from Bosch or third-party suppliers can be easily integrated. The machine can also be equipped with the Bosch CPI software, which manages serialisation from the allocation of serial numbers through to the last aggregation step. Thus, the Sigpack TTMP fulfils the most recent serialisation requirements for pharmaceutical products.

Various monitoring functions inspect the packaging process at several points. For instance, the carton blanks are already scanned at the infeed. Vision systems and code verification allow to examine carton contents, the correct infeed of the package inserts, as well as the intact shape of the cartons. Incorrect packs are automatically dispatched from the system by discharging devices. This concept ensures 100 per cent process control and also speeds up line clearance during batch change.

Contact Details:
Michael Haas, Christin Poenisch
Tel: +41 58 674-8594

The post Bosch introduces new pharma cartoner Sigpack TTMP appeared first on Express Pharma.

ADVANCED INDUSTRIAL MICRO SYSTEMS (AIMS), a leading manufacturer and exporter of high precision marking, printing and packaging systems for coding variable information like Batch No., Mfg. Date, Exp. Date, Max. Retail Price, etc. on any substrate, which is stationary or moving, has launched hand held ink jet printers model U2-Mobile.

The light industrial handheld non-contact ink jet printer model IJP – Elfin IH, is a 4-in-1 compact design, zero maintenance, 300 dpi high resolution, battery powered six line (character height 1 to 12.7 mm) printer and can be used on porous/ non-porous products to print B.No., Exp.Date, Time, Serial No. (AGMARK), logos, scannable variable bar codes, etc. on labels, cartons, pouches, drums, containers, etc. It is fully programmable using the five inch full colour touch screen LCD with stand-alone operation (no PC required) where it can print six lines data and all computer fonts (local languages).

The other product launched by AIMS is low cost on-line industrial non-contact ink jet printer model IJP – P2128 (Maplejet-Canada). It is a zero maintenance, high resolution, four line (character height 1 to 18 mm) English/ Arabic printer. It has stainless steel construction and can be installed on porous and non-porous production lines to print B.No., Mfg.Date, Exp.Date, MRP, Time, Serial No. (AGMARK), etc. on bottles, pouches, labels, cartons, pipes, etc. Through the COM Port (RS-232) computer link, it is also capable of printing high quality logos, scannable bar codes, Hindi/ local language and upto eight lines data in any computer font.

All the products have been designed and developed with in-house R&D facilities keeping in mind the extreme conditions of the industrial environment. They have been developed to give highly dependable, trouble free, consistent and high performance at a very competitive price.

Contact Details:
Advanced Industrial Micro Systems
201, Triumph Industrial Estate,
Itt Bhatti – Paanch Baawdi,
Opp Express Zone – A Wing,
Near Dindoshi Signal,
Goregaon (East),
Mumbai – 400 063, INDIA.
Phone: (022) 32964272, 28766351, 28756353
Fax: (+91-22) 28766352
Email: SamirGarg.AIMS@gmail.com / info@coding-india.com
Website: www.coding-india.com / www.printpackaging.in

The post AIMS launches non-contact ink jet printers appeared first on Express Pharma.